This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Eng, J. Articles by Gallagher, R. Search for Related Content PubMed PubMed Citation Articles by Eng, J. Articles by Gallagher, R. Social Bookmarking                         What's this?

A Population-Based Survey of Complementary and Alternative Medicine Use in Men Recently Diagnosed with Prostate Cancer

Tzu Chi Research Group, Vancouver, BC

Darlene Ramsum, PhD

Department of Clinical Epidemiology and Evaluation, Vancouver Hospital and Health Sciences Centre, Vancouver BC

Marja Verhoef, PhD

Tzu Chi Reseach Group, Vancouver, BC, Department of Community Health Sciences, University of Calgary, Calgary, AB, mverhoef{at}ucalgary.ca

Emma Guns, PhD

Prostate Centre at Vancouver General Hospital, Vancouver, BC

Joyce Davison, PhD

Prostate Centre at Vancouver General Hospital, Vancouver, BC

Richard Gallagher, FACE, MSc

British Columbia Cancer Agency, Vancouver, BC

Purpose: To determine prevalence and patterns of use of complementary and alternative medicine (CAM) among men recently diagnosed with prostate cancer. Study Design: Men, diagnosed with prostate cancer over a 10-month period in British Columbia, Canada, were randomly selected to obtain a population-based sample. Methods: Surveys, addressing patient demographics, types of CAM therapies, and CAM information resources utilized, reasons for use, and disclosure to physician(s), were mailed to 1108 men newly diagnosed with prostate cancer. A 42% response rate was obtained. Results: Thirty-nine percent of patients used CAM therapies with the most common being herbal supplements (saw palmetto), vitamins (vitamin E), and minerals (selenium). The most common reasons given for choosing to use CAM therapies were to (1) boost the immune system and (2) prevent recurrence. The majority of men (58%) had told their physician(s) about their CAM use, but few utilized either their family physician (15%) or their oncologist (7%) as sources of CAM information. CAM users most commonly consulted friends or family (39%) or the Internet (19%) for information about CAM. CAM users were more likely than nonusers to delay (9%) or decline (4%) conventional treatment. Respondents who had never used CAM had typically never thought about it or did not have enough information about the treatments. Conclusions: More than one third of recently diagnosed prostate cancer patients utilize some form of CAM therapy, and the majority disclose their use to their physician(s). However, they tend to rely on anecdotal information for their CAM decision making. Dissemination of reliable CAM information is one key to helping men navigate this difficult arena.

Key Words: prostate • neoplasms • complementary therapies • alternative therapies

Integrative Cancer Therapies, Vol. 2, No. 3, 212-216 (2003)
DOI: 10.1177/1534735403256207


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. C. Porter and M. A. Diefenbach Pushed and Pulled: The Role of Affect and Cognition in Shaping CAM Attitudes and Behavior among Men Treated for Prostate Cancer J Health Psychol, March 1, 2009; 14(2): 288 - 296. [Abstract] [PDF]

				M. H Hanigan, B. L dela Cruz, D. M Thompson, K. C Farmer, and P. J Medina Use of prescription and nonprescription medications and supplements by cancer patients during chemotherapy: questionnaire validation Journal of Oncology Pharmacy Practice, September 1, 2008; 14(3): 123 - 130. [Abstract] [PDF]

				A. Broom and P. Tovey The role of the Internet in cancer patients' engagement with complementary and alternative treatments Health (London) , April 1, 2008; 12(2): 139 - 155. [Abstract] [PDF]

				F. M. Sirois and R. J. Purc-Stephenson Consumer Decision Factors for Initial and Long-Term Use of Complementary and Alternative Medicine Complementary Health Practice Review, January 1, 2008; 13(1): 3 - 19. [Abstract] [PDF]

				M. White and M. Verhoef Cancer as Part of the Journey: The Role of Spirituality in the Decision to Decline Conventional Prostate Cancer Treatment and to Use Complementary and Alternative Medicine Integr Cancer Ther, June 1, 2006; 5(2): 117 - 122. [Abstract] [PDF]

				D. M. Hann, F. Baker, C. S. Roberts, C. Witt, J. McDonald, M. Livingston, J. Ruiterman, R. Ampela, C. Crammer, and O. Kaw Use of Complementary Therapies Among Breast and Prostate Cancer Patients During Treatment: A Multisite Study Integr Cancer Ther, December 1, 2005; 4(4): 294 - 300. [Abstract] [PDF]

				H. Singh, G. Maskarinec, and D. M. Shumay Understanding the Motivation for Conventional and Complementary/Alternative Medicine Use Among Men With Prostate Cancer Integr Cancer Ther, June 1, 2005; 4(2): 187 - 194. [Abstract] [PDF]